Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 18Recruiting 8Withdrawn 3Terminated 3Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 1

Conditions

Colorectal Neoplasms 44Squamous Cell Carcinoma of Head and Neck 22Head and Neck Neoplasms 21Rectal Neoplasms 17Colonic Neoplasms 15Neoplasm Metastasis 13Neoplasms 12Carcinoma, Squamous Cell 10Carcinoma, Non-Small-Cell Lung 10Recurrence 5Pancreatic Neoplasms 5Esophageal Neoplasms 4Mouth Neoplasms 3Lung Neoplasms 3Laryngeal Neoplasms 3Laryngeal Diseases 3Breast Neoplasms 3Tongue Neoplasms 2Stomach Neoplasms 2Sarcoma 2Pharyngeal Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms, Squamous Cell 2Hereditary Sensory and Autonomic Neuropathies 2Glioma 2Glioblastoma 2Colorectal Cancer Metastatic 2Adenocarcinoma of Lung 2Adenocarcinoma Of Esophagus 2

Interventions

Carboplatin 49Pemetrexed 38Cisplatin 34Radiotherapy 32Docetaxel 31Gemcitabine 25Paclitaxel 24Nivolumab 18pembrolizumab 15Etoposide 15Radiosurgery 13Erlotinib Hydrochloride 11Bevacizumab 11Magnetic Resonance Spectroscopy 10Vinorelbine 9Radiation 9Cyclophosphamide 7durvalumab 6Gefitinib 6Fluorodeoxyglucose F18 6Celecoxib 6atezolizumab 5Oxaliplatin 5Irinotecan 5Immunoglobulin G 5Drug Therapy 5Disulfides 5Dexamethasone 5Chemotherapy, Adjuvant 5vandetanib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Lung Neoplasms × Cetuximab × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT00519831 2017-06-09

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
18 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00288054 2013-01-04

S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

SWOG Cancer Research Network

Phase 1 Terminated
24 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡